Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Ocular Therapeutix (OCUL) over the last 12 years, with Q4 2025 value amounting to $76000.0.

  • Ocular Therapeutix's Change in Inventory fell 8803.15% to $76000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $524000.0, marking a year-over-year decrease of 2870.75%. This contributed to the annual value of $524000.0 for FY2025, which is 2870.75% down from last year.
  • Per Ocular Therapeutix's latest filing, its Change in Inventory stood at $76000.0 for Q4 2025, which was down 8803.15% from $449000.0 recorded in Q3 2025.
  • In the past 5 years, Ocular Therapeutix's Change in Inventory registered a high of $635000.0 during Q4 2024, and its lowest value of -$230000.0 during Q2 2025.
  • In the last 5 years, Ocular Therapeutix's Change in Inventory had a median value of $64500.0 in 2023 and averaged $118150.0.
  • Its Change in Inventory has fluctuated over the past 5 years, first surged by 143214.29% in 2022, then crashed by 75185.19% in 2025.
  • Ocular Therapeutix's Change in Inventory (Quarter) stood at $28000.0 in 2021, then surged by 1432.14% to $429000.0 in 2022, then crashed by 88.81% to $48000.0 in 2023, then skyrocketed by 1222.92% to $635000.0 in 2024, then tumbled by 88.03% to $76000.0 in 2025.
  • Its Change in Inventory was $76000.0 in Q4 2025, compared to $449000.0 in Q3 2025 and -$230000.0 in Q2 2025.